Search Within

Eytan Moshe Stein

Formats
  1. Meeting Abstract (217)
  2. Journal Article (104)
  3. Review (17)
  4. Research Letter (14)
  5. Editorial (5)
  6. Book Section (3)
  7. Guidelines (2)
  8. Correspondence (1)
  9. Miscellaneous (1)
Groups
  1. Adult Leukemia (364)
  2. Center for Hematologic Malignancies (364)
  3. Department of Medicine (364)
  4. Hematologic Malignancies, Division of (364)
  5. GSK Faculty (92)
  6. Executive Committee, Center for Hematologic Malignancies (87)

More Groups

People
  1. Martin Tallman (116)
  2. Ross Levine (75)
  3. Aaron Goldberg (41)
  4. Jan Bewersdorf (33)
  5. Andriy Derkach (31)
  6. Christopher Famulare (30)

More People

Years
  1. 2025 (14)
  2. 2024 (44)
  3. 2023 (49)
  4. 2022 (34)
  5. 2021 (31)
  6. 2020 (30)

More Years

Publications
  1. Blood (170)
  2. Journal of Clinical Oncology (23)
  3. Clinical Lymphoma, Myeloma and Leukemia (17)
  4. Haematologica (16)
  5. Blood Advances (14)
  6. Leukemia and Lymphoma (12)

More Publications

Publishers
  1. American Society of Hematology (185)
  2. Elsevier Inc. (30)
  3. American Society of Clinical Oncology (27)
  4. Ferrata Storti Foundation (16)
  5. Nature Publishing Group (15)
  6. Taylor & Francis Group (12)

More Publishers

Results (364)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era
    Meeting Abstract

    Mantha, S.; Goldman, D.; Devlin, S. M.; Lee, J. W.; Zannino, D.; Douer, D.; Iland, H. J.; Litzow, M. R.; Stein, E. M.; Appelbaum, F.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Patient derived xenograft (PDX) models recapitulate the genomic-driver composition of acute leukemia samples
    Meeting Abstract

    Krivtsov, A. V.; Wang, X. J.; Farnoud, N. R.; Hadler, M.; Martin, M. S.; Knapp, K. M.; Stein, E. M.; Lipson, D.; Nahas, M. K.; Stephens, P. J.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Secondary ALL may be independent of prior cytotoxic therapy
    Meeting Abstract

    Ganzel, C.; Devlin, S. M.; Douer, D.; Stein, E. M.; Rowe, J. M.; Tallman, M. S.
    Blood (2014)

    Fulltext@MSK | Save
  • Utility of combined DNA and RNA next generation sequencing in leukemias for identification of prognostic and therapeutically relevant genomic alterations in clinical practice
    Meeting Abstract

    Coombs, C. C.; Viny, A. D.; He, J.; Kobos, R.; Lipson, D.; Shukla, N.; Knapp, K. M.; Otto, G.; Abdel-Wahab, O.; Stein, E. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Telomere length recovery strongly predicts overall survival in acute promyelocytic leukemia
    Meeting Abstract

    Baljevic, M.; Dumitriu, B.; Lee, J. W.; Paietta, E.; Racevskis, J.; Chen, C.; Stein, E. M.; Gallagher, R. E.; Rowe, J. M.; Appelbaum, F. R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Clinical safety and activity in a phase I trial of AG-120, a first in class, selective, potent inhibitor of the IDH1-mutant protein, in patients with IDH1 mutant positive advanced hematologic malignancies
    Meeting Abstract

    Pollyea, D. A.; de Botton, S.; Fathi, A. T.; Stein, E. M.; Tallman, M. S.; Agresta, S.; Bowden, C.; Fan, B.; Prah, M.; Yang, H.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Treatment with radiation, chemotherapy, or both demonstrates similar outcomes in patients with isolated myeloid sarcoma that may not be different than de novo acute myeloid leukemia
    Meeting Abstract

    Feller, F. M.; Devlin, S. M.; Stein, E. M.; Tallman, M. S.; Rampal, R. K.
    Haematologica (2014)

    Fulltext@MSK | Save
  • A phase I study of Ag-221, a first in class, potent inhibitor of the Idh2-mutant protein, in patients with Idh2 mutant positive advanced hematologic malignancies
    Meeting Abstract

    Agresta, S.; Stein, E. M.; Tallman, M. S.; Levine, R. L.; Yua, H.; Yen, K.; Fan, B.; Flinn, I. W.; Fathi, A. T.; Stone, R. M.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Acute promyelocytic leukemia in children and adolescents
    Journal Article

    Stein, E. M.; Tallman, M. S.
    Acta Haematologica (2014)

    Fulltext@MSK | Save
  • Do patients with high risk or relapsed core binding factor acute myeloid leukemia benefit from salvage allogeneic stem cell transplantation?
    Meeting Abstract

    Hobbs, G.; Kishtagari, A.; Hilden, P.; Barker, J. N.; Jakubowski, A. A.; Papadopoulos, E.; Devlin, S.; Boulad, F.; Kernan, N.; Kobos, R.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save